Sanofi Consumer Healthcare India Limited (SANOFICONR) Financial History

Name: Sanofi Consumer Healthcare India Limited (SANOFICONR) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - General · DATA UPDATED 2026-09-20

Sanofi Consumer Healthcare India Limited (SANOFICONR) operates in the Drug Manufacturers - General industry and is headquartered in Mumbai, India with about 597 employees. Its market capitalization is roughly ₹93 billion. In the fiscal year ended 2025-12-31, SANOFICONR reported ₹8.8B in revenue and ₹2.4B in net income.

Sanofi Consumer Healthcare India Limited operates as a fast-moving consumer healthcare company in India.

Interactive charts & full statements →

SANOFICONR Revenue & Earnings History — Annual Income Statement

Income statement	2025-12-31	2024-12-31	2023-12-31
Total Revenue	₹8.8B	₹7.2B	₹5.4B
Gross Profit	₹6.0B	₹4.9B	₹3.5B
Operating Income (EBIT)	₹3.0B	₹2.7B	₹2.2B
Net Income	₹2.4B	₹1.8B	₹1.6B

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SANOFICONR Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Total Revenue	₹2.4B	₹2.3B	₹2.5B	₹2.3B	₹2.2B
Gross Profit	₹1.8B	₹1.7B	₹1.8B	₹1.7B	₹1.6B
Operating Income (EBIT)	₹860M	₹856M	₹864M	₹817M	₹672M
Net Income	₹688M	₹678M	₹665M	₹629M	₹607M

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SANOFICONR Free Cash Flow History

Cash flow	2025-12-31	2024-12-31	2023-12-31
Dividends Paid	(₹1.3B)	(₹1.2B)	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SANOFICONR Balance Sheet History

Balance sheet	2025-12-31	2024-12-31	2023-12-31
Total Assets	₹5.5B	₹4.3B	₹3.5B
Total Liabilities	₹1.6B	₹1.6B	₹1.4B

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SANOFICONR viewer.

Other Companies in Drug Manufacturers - General

NOVN · Novartis AG — CHF 219 billion
PFIZER · Pfizer Limited — ₹183 billion
MARKSANS · Marksans Pharma Limited — ₹145 billion
1093 · CSPC Pharmaceutical Group Limited — HK$102 billion
SANOFI · Sanofi India Limited — ₹71 billion
SYMBIOTEC · SYMBIOTEC PHARMALAB LTD — ₹70 billion
SENORES · Senores Pharmaceuticals Limited — ₹65 billion
4552 · JCR Pharmaceuticals Co., Ltd. — JPY 63 billion

← SANOFI All “S” companies SANSERA →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.